ArticleLancet regional health. Americas2025

Immunogenicity and reactogenicity of fractional vs. full booster doses of COVID-19 vaccines: a non-inferiority, randomised, double-blind, phase IV clinical trial in Brazil.

Marco Antonio Moreira Puga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.